Here are relevant reports on : hifu-ultrasound-market
-
Thrombectomy Devices Market by Type (Hydrodynamic, Ultrasound, Aspiration, Mechanical Thrombectomy), Application (Cardiovascular, Peripheral, Neurovascular), End User (Hospitals, Surgical Centers, Ambulatory, Academia, CROs)- Global Forecast to 2022
The global thrombectomy devices market is projected to grow at a CAGR of 6.7% . Some of the prominent players in the market are Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), Johnson & Johnson (U.S.), Terumo Corporation (Japan), Penumbra, Inc. (U.S.), Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), and Teleflex Incorporated (U.S.), were few other key players operating in the market.
- Published: April 2017
- Price: $ 4950
- TOC Available:
-
3D and 4D Ultrasound Market by Type, End-Use Industry, Application and Region – Global Forecast to 2030
Ultrasound technology has undergone significant advancements over the years, with 3D and 4D ultrasound imaging providing valuable insights in medical diagnostics and prenatal care.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Neurodiagnostics Market by Product (Diagnostic & Imaging Systems (MRI, Ultrasound), Clinical Testing (PCR, NGS), Reagents & Consumables), Disease Pathology (Epilepsy, Stroke), End User and Region - Global Forecasts to 2024
The neurodiagnostics market is projected to reach USD 8.4 billion by 2024, at a CAGR of 7.3%. Some of the prominent players in this market includes GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Hitachi, Ltd. (Japan), Canon, Inc. (Japan), Lifelines Neuro Company, LLC (US), Natus Medical Incorporated (US), Hoffman-La Roche AG (Switzerland), FUJIFILM Holdings Corporation (Japan), Mitsar Co., Ltd. (Russia), Advanced Brain Monitoring (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories (US), QIAGEN N.V. (Netherlands), Nihon Kohden Corporation (Japan), ANT Neuro (Netherlands), Fonar Corporation (US), Fujirebio (Japan), DRG Instruments GmbH (Germany), Tecan Trading AG (Switzerland), Motion Lab Systems, Inc. (US), Rigaku Corporation (Japan), Neusoft Medical Systems Co., Ltd. (US), ELMIKO MEDICAL Sp. Z o.o. (Poland) and Ridge Diagnostics (US).
- Published: December 2019
- Price: $ 4950
- TOC Available:
-
Ultrasound Probe Covers Market by Type (Disposable, Reusable), Material (Latex, Latex-free), Application (Endocavitary), End User (Hospitals, Diagnostic Imaging Centers, Maternity Centers, Ambulatory Surgical Centers) & Region - Global Forecast to 2027
The global ultrasound probe covers market in terms of revenue was estimated to be worth $213 million in 2022 and is poised to reach $283 million in 2027, growing at a CAGR of 5.9% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: February 2023
- Price: $ 4950
- TOC Available:
-
Lymphedema Diagnostics Market by Technology (Lymphoscintigraphy, MRI, Near IR Fluorescence Imaging, Ultrasound), Disease Type (Cancer, Inflammatory Diseases, Cardiovascular, Filariasis), End User (Hospitals, Diagnostic Centers) - Global Forecasts to 2024
The Lymphedema Diagnostics Market is expected to grow from USD 24 million in 2019 to USD 35 million by 2024, at a CAGR of 7.4% during the forecast period. The major players operating in the lymphedema diagnostics market are GE Healthcare (US), Philips (Netherlands), and Siemens Healthineers (Germany). Other prominent players in this market include Canon, Inc. (Japan), Shimadzu Corporation (Japan), Stryker Corporation (US), Fluoptics (France), United Imaging Healthcare Co., Ltd. (China), Hitachi, Ltd. (Japan), Esaote, SpA (Italy), Neusoft Corporation (China), Mindray Medical International, Ltd. (China), Mitaka USA, Inc. (US), Curadel, LLC (US), and ImpediMed Ltd. (Australia).
- Published: October 2019
- Price: $ 4950
- TOC Available:
-
Ultrasound Needle Guides Market by Type (Reusable, Disposable), Application (Tissue Biopsy, Fluid Aspiration, Nerve Block, Regional Anesthesia, Vascular Access), End User (Hospitals, Clinics, ASC, Diagnostic Imaging Centers) & Region - Global Forecasts to 2027
The global ultrasound needle guides market, stood at US$274 million in 2022 and is projected to advance at a resilient CAGR of 6.1% from 2022 to 2028, culminating in a forecasted valuation of US$369 billion by the end of the period. Ultrasound needle guides have applications in the diagnosis and treatment of diseases such as cancer and CVD. The prevalence of these target diseases is increasing across the globe due to factors such as the rising geriatric population and the increasing adoption of sedentary lifestyles.
- Published: February 2023
- Price: $ 4950
- TOC Available:
-
Food Ultrasound Market by Frequency Range (High-intensity and Low-intensity), Food Product (Meat, Beverages, F&V, Dairy, Bakery), Function (Microbial Inactivation, Quality Assurance, Homogenization, Cutting), and Region - Global forecast to 2022
The food ultrasound market was valued at USD 87.7 Million in 2016. It is projected to reach USD 134.6 Million by 2022, growing at a CAGR of 7.5% from 2017. Ultrasound technology is used for the processing of various food products such as meat & food, fruits & vegetables, beverages, dairy, bakery & confectionery, and others (cereals, grains, pulses, nuts, seeds, spices, and packaged foods). This report includes a study of the business strategies, along with the product portfolios of leading companies. It includes the profiles of leading companies such as Bosch (Germany), Emerson (US), Bühler (Switzerland), Dukane (US), and Heilscher (Germany).
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
Non Invasive Prenatal Testing Market by Product (Consumables, Reagent, Ultrasound, NGS, PCR, Microarray), Services, Method (cfDNA, Biochemical Markers), Application (Aneuploidy, Microdeletion) & End-User (Hospital, Labs) - Global Forecasts to 2029
The global non invasive prenatal testing market, valued at US$6.4 billion in 2023, stood at US$7.2 billion in 2024 and is projected to advance at a resilient CAGR of 14.5% from 2024 to 2029, culminating in a forecasted valuation of US$14.1 billion by the end of the period. The primary growth factors propelling this market include spiking investments, incentives, and support from both state governments and private companies, which are driving access to and demand for NIPT technologies.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
US Medical Simulation Market by offering (Anatomical Models [Patient {High Fidelity}, Surgical {Laparoscopic, Ortho, Gynec, Spine}, Trainers, Ultrasound], Software), Technology (3D Printing, Virtual Patient, Procedural Rehearsal), End User - Forecast 2030
The US Medical Simulation market, valued at USD 1.20 billion in 2024, stood at USD 1.40 billion in 2025 and is projected to advance at a resilient CAGR of 15.2% from 2025 to 2030, culminating in a forecasted valuation of USD 2.83 billion by the end of the period. The US medical simulation market continues to expand, supported by rising demand for advanced clinical training, stricter regulatory and accreditation requirements, and a growing healthcare workforce.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Biopsy Devices Market by Product (Core needle biopsy (Automatic, Disposable), Technology (Ultrasound,stereotactic), Application (Oncology, Gastroenterology, Bone & Bone marrow biopsy), End User (Diagnostic imaging centres) - Global Forecast to 2030
The global biopsy devices market, valued at US$6.86B in 2023, is forecasted to grow at a 7.2% CAGR, reaching US$7.27B by 2024 and US$11.01B by 2030. The rising prevalence of cancer. Additionally the increasing preference for minimally invasive surgeries. Moreover, the improved reimbursement policies is likely to promote the growth of biopsy device market.
- Published: March 2025
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
